Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
0.3376 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||||
Net Income
| -116.658 | -110.218 | -92.287 | -50.463 | -28.618 | -26.089 | -21.123 | -38.842 | -48.054 | -27.616 | -10.884 | -9.45 | -3.47 | -0.018 | -0.031 | -0.021 |
Depreciation & Amortization
| 4.291 | 1.253 | 0.05 | 0.027 | 0.026 | 0.054 | 0.07 | 0.206 | 0.161 | 0.036 | 0.017 | 0.014 | 0.009 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | -14.465 | 0 | 0 | 0.154 | 0 | 0 | 0 | 0 | 0 | 0 | 1.177 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 9.275 | 10.914 | 7.899 | 2.876 | 1.457 | 1.627 | 1.79 | 3.266 | 4.389 | 3.088 | 1.717 | 0.865 | 0.436 | 0 | 0 | 0 |
Change In Working Capital
| -0.035 | -0.002 | 5.781 | -2.366 | 0.452 | 0.437 | 0.135 | -2.078 | 0.976 | 1.044 | 0.582 | 0.267 | 0.334 | -0 | 0.003 | -0.002 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -3.49 | -1.045 | 3.526 | 1.528 | 1.663 | 0.106 | 0.424 | -2.185 | 1.583 | 0.728 | -0.06 | 0.131 | 0.377 | -0.001 | 0.001 | 0 |
Other Working Capital
| 3.394 | 1.043 | 2.255 | -3.894 | -1.211 | 0.331 | -0.289 | 0.107 | -0.607 | 0.316 | 0.642 | 0.136 | -0.043 | 0 | 0.002 | -0.002 |
Other Non Cash Items
| 1.124 | 14.465 | 3 | 1.36 | -0.154 | 1.629 | 1.5 | 0.133 | 3.063 | 0.608 | 0.051 | 1.414 | 0.053 | 0 | 0 | 0 |
Operating Cash Flow
| -102.003 | -98.053 | -75.557 | -48.566 | -26.683 | -23.971 | -19.128 | -37.315 | -42.528 | -22.84 | -8.517 | -5.713 | -2.638 | -0.018 | -0.028 | -0.024 |
Investing Activities: | ||||||||||||||||
Investments In Property Plant And Equipment
| -7.895 | -48.147 | -35.307 | -8.564 | -0.017 | -0.006 | -0.005 | -0.066 | -0.238 | -0.319 | -0.015 | -0.036 | -0.003 | 0 | 0 | 0 |
Acquisitions Net
| -22.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28.643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 7.174 | 16.615 | 4.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0.999 | 0 | 0 | 0 | -0.017 | -0.006 | 7.174 | 0.045 | -0.12 | -0.073 | -0.015 | -0 | 0.003 | 0 | 0 | 0 |
Investing Cash Flow
| -29.07 | -48.147 | -35.307 | -8.564 | -0.017 | -0.006 | 7.169 | 16.594 | -24.171 | -0.392 | -0.015 | -0.036 | 0 | 0 | 0 | 0 |
Financing Activities: | ||||||||||||||||
Debt Repayment
| 8.942 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.28 | 0.56 | 2.001 | 0.05 | 0 | 0 |
Common Stock Issued
| 18.939 | 135.094 | 212.389 | 108.605 | 5.838 | 12.714 | 18.505 | 20.498 | 47.685 | 47.836 | 10.042 | 6.933 | 0.612 | 0 | 0 | 0.05 |
Common Stock Repurchased
| -13.965 | -47.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | -6.659 | 0 | -0.451 | -2.474 | -3.266 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 22.601 | 0.04 | 0.098 | 14.951 | 9.555 | 14.091 | 0.014 | 0 | 0.009 | 53.217 | 14.67 | -0 | 0 | 1.342 | 0 | 0 |
Financing Cash Flow
| 36.517 | 87.844 | 212.487 | 123.105 | 12.919 | 23.539 | 18.519 | 20.498 | 47.694 | 53.217 | 14.95 | 7.493 | 2.613 | 0.01 | 0 | 0.05 |
Other Information: | ||||||||||||||||
Effect Of Forex Changes On Cash
| -0.065 | -0.074 | -0.031 | -0.016 | -0.004 | -0.013 | -0.005 | -0.011 | -0.004 | -0.003 | -0.001 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -94.621 | -58.43 | 101.592 | 65.959 | -13.785 | -0.451 | 6.555 | -0.234 | -19.009 | 29.982 | 6.417 | 1.744 | -0.024 | -0.008 | -0.028 | 0.026 |
Cash At End Of Period
| 25.849 | 120.47 | 178.9 | 77.308 | 11.349 | 25.134 | 25.585 | 18.941 | 19.175 | 38.184 | 8.202 | 1.785 | 0.041 | 0.005 | 0.013 | 0.04 |